Du, P.; Wang, T.; Wang, R.; Liu, S.; Wang, H.; Yin, H.
A Novel Recombinant Human FGF21 Analog with High Glycosylation Has a Prolonged Half-Life and Affects Glycemic and Body Weight Control. Int. J. Mol. Sci. 2025, 26, 2672.
https://doi.org/10.3390/ijms26062672
AMA Style
Du P, Wang T, Wang R, Liu S, Wang H, Yin H.
A Novel Recombinant Human FGF21 Analog with High Glycosylation Has a Prolonged Half-Life and Affects Glycemic and Body Weight Control. International Journal of Molecular Sciences. 2025; 26(6):2672.
https://doi.org/10.3390/ijms26062672
Chicago/Turabian Style
Du, Pei, Ting Wang, Rong Wang, Shang Liu, Hang Wang, and Hongping Yin.
2025. "A Novel Recombinant Human FGF21 Analog with High Glycosylation Has a Prolonged Half-Life and Affects Glycemic and Body Weight Control" International Journal of Molecular Sciences 26, no. 6: 2672.
https://doi.org/10.3390/ijms26062672
APA Style
Du, P., Wang, T., Wang, R., Liu, S., Wang, H., & Yin, H.
(2025). A Novel Recombinant Human FGF21 Analog with High Glycosylation Has a Prolonged Half-Life and Affects Glycemic and Body Weight Control. International Journal of Molecular Sciences, 26(6), 2672.
https://doi.org/10.3390/ijms26062672
